Efficacy and safety of osimertinib for leptomeningeal metastases from EGFR-mutant non-small cell lung cancer: a pooled analysis

被引：0
|
作者：
Lei Wen
Junjie Zhen
Changguo Shan
Mingyao Lai
Weiping Hong
Hui Wang
Mingting Ye
Yanying Yang
Shaoqun Li
Zhaoming Zhou
Jiangfen Zhou
Qingjun Hu
Juan Li
Xuwei Tian
Longhua Chen
Linbo Cai
Zhanhong Xie
Cheng Zhou
机构：
[1] Guangdong Sanjiu Brain Hospital,Department of Oncology
[2] The First People’s Hospital of Kashi Prefecture,Department of Radiation Oncology
[3] Southern Medical University,Department of Radiation Oncology, Nanfang Hospital
[4] The First Affiliated Hospital of Guangzhou Medical University,State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute for Respiratory Health
来源：
European Journal of Medical Research | / 28卷
关键词：
Osimertinib; EGFR; NSCLC; Leptomeningeal metastases (LM); Efficacy; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Standard dose osimertinib for erlotinib refractory T790M-negative EGFR-mutant non-small cell lung cancer with leptomeningeal disease
    Arulananda, Surein
    Do, Hongdo
    Rivalland, Gareth
    Loh, Zoe
    Musafer, Ashan
    Lau, Eddie
    Mitchell, Paul
    Dobrovic, Alexander
    John, Thomas
    JOURNAL OF THORACIC DISEASE, 2019, 11 (05) : 1756 - 1764
  • [42] Leptomeningeal metastases in non-small cell lung cancer patients with EGFR mutations
    Li, Y-S.
    Jiang, B-Y.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [43] Prognostic value of EGFR genotype in EGFR-mutant non-small cell lung cancer
    Syrigos, Konstantinos
    Kotteas, Ilias
    Paraskeva, Maria
    Gkiozos, Ioannis
    Boura, Paraskevi
    Tsagouli, Sofia
    Grapsa, Dimitra
    Charpidou, Andriani
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [44] Real-World Case Series on Efficacy and Safety of Amivantamab for EGFR-mutant Non-small Cell Lung Cancer
    Le, X.
    Du, R.
    Lewis, W. E.
    Hong, L.
    Skoulidis, F.
    Byers, L.
    Tsao, A.
    Cascone, T.
    Pozadzides, J.
    Tu, J.
    Negrao, M. V.
    Baik, C.
    Zhang, J.
    Heymach, J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S484 - S484
  • [45] The past, present, and future management of brain metastases in EGFR-mutant non-small cell lung cancer
    Sperduto, Paul W.
    Lou, Emil
    NEURO-ONCOLOGY, 2021, 23 (06) : 867 - 868
  • [46] Osimertinib combined with durvalumab in EGFR-mutant non-small cell lung cancer: Results from the TATTON phase Ib trial
    Ahn, M. -J.
    Yang, J.
    Yu, H.
    Saka, H.
    Ramalingam, S.
    Goto, K.
    Kim, S. -W.
    Yang, L.
    Walding, A.
    Oxnard, G. R.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S115 - S115
  • [47] MERTK activation drives osimertinib resistance in EGFR-mutant non small cell lung cancer
    Yan, Dan
    Huelse, Justus M.
    Kireev, Dmitri
    Tan, Zikang
    Chen, Luxiao
    Goyal, Subir
    Wang, Xiaodong
    Frye, Stephen, V
    Behera, Madhusmita
    Schneider, Frank
    Ramalingam, Suresh S.
    Owonikoko, Taofeek
    Earp, H. Shelton
    DeRyckere, Deborah
    Graham, Douglas K.
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (15):
  • [48] Impact of body surface area on efficacy and safety in patients with EGFR-mutant non-small cell lung cancer treated with osimertinib as a first-line treatment
    Tanaka, Saki
    Tamiya, Motohiro
    Nishiuma, Satoshi
    Nakamura, Sayaka
    Nozaki, Keisuke
    Watanabe, Naoko
    Itoh, Chisae
    Kadokawa, Yukio
    Takeda, Kenji
    Takahashi, Kozo
    Miyazaki, Akito
    Kawamura, Takahisa
    Kunimasa, Kei
    Inoue, Takako
    Nishino, Kazumi
    Takagi, Mari
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2024, 40
  • [49] Dihydroartemisinin overcomes the resistance to osimertinib in EGFR-mutant non-small-cell lung cancer
    Cai, Xueting
    Miao, Jing
    Sun, Rongwei
    Wang, Sainan
    Molina-Vila, Miguel Angel
    Chaib, Imane
    Rosell, Rafael
    Cao, Peng
    PHARMACOLOGICAL RESEARCH, 2021, 170
  • [50] Efficacy of Tyrosine Kinase Inhibitors in EGFR Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases
    Flippot, R.
    Auclin, E.
    Biondani, P.
    Le Rhun, E.
    Adam, J.
    Planchard, D.
    Caramella, C.
    Le Pechoux, C.
    Lacroix, L.
    Gazzah, A.
    Mezquita, L.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S467 - S467
12345